Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy

Original Article

F.C. Fervenza, F.F. Hou, C.-M. Hao, G.M. Kirsztajn, L. Gesualdo, T. Hryszko, A. Pisani, D. Roccatello, A.S. Bomback, J. Rae, F. Barmaki, E. Berisha, T. Schindler, T.A. Omachi, J.P. Garg, and A. Malvar

N Engl J Med 2026;395:959-971

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
09/09/2026
Course expires: 
09/10/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.